相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Francois Lamontagne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies and potential mechanisms
Chengyu Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
The immunology of sepsis
Tom van der Poll et al.
IMMUNITY (2021)
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Laura Evans et al.
INTENSIVE CARE MEDICINE (2021)
The Epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional Survey
Jianfeng Xie et al.
CRITICAL CARE MEDICINE (2020)
Marked Reduction in 28-day Mortality Among Elderly Patients with Severe Community-acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial
Yan Liu et al.
CLINICAL INTERVENTIONS IN AGING (2020)
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy The SCARLET Randomized Clinical Trial
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial
Yuanlin Song et al.
CRITICAL CARE MEDICINE (2019)
Population enrichment for critical care trials: phenotypes and differential outcomes
Manu Shankar-Hari et al.
CURRENT OPINION IN CRITICAL CARE (2019)
High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care
Jian Li et al.
ACTA PHARMACEUTICA SINICA B (2019)
Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial
Songqiao Liu et al.
BMJ OPEN (2019)
Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
Xi Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials
Chengyu Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll et al.
NATURE REVIEWS IMMUNOLOGY (2017)
The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience
James A. Russell et al.
CRITICAL CARE MEDICINE (2017)
Severe Sepsis and Septic Shock Trials (ProCESS, ARISE, ProMISe) What is Optimal Resuscitation?
Tiffany M. Osborn
CRITICAL CARE CLINICS (2017)
Xuebijing in the treatment of patients with sepsis
Heng Shi et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Early goal-directed therapy in the management of severe sepsis or septic shock in adults: a meta-analysis of randomized controlled trials
Ling Zhang et al.
BMC MEDICINE (2015)
Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice
Qiao Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Xuebijing Injection Promotes M2 Polarization of Macrophages and Improves Survival Rate in Septic Mice
Yan-Cun Liu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Protective effect of Xuebijing injection on paraquat-induced pulmonary injury via down-regulating the expression of p38 MAPK in rats
Ming-wei Liu et al.
BMC Complementary and Alternative Medicine (2015)
Heat Stress-Induced Disruption of Endothelial Barrier Function Is via PAR1 Signaling and Suppressed by Xuebijing Injection
Qiulin Xu et al.
PLOS ONE (2015)
The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?
Steven M. Opal et al.
CRITICAL CARE MEDICINE (2014)
Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
Qin Yin et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Mitigating the Effects of Xuebijing Injection on Hematopoietic Cell Injury Induced by Total Body Irradiation with γ rays by Decreasing Reactive Oxygen Species Levels
Deguan Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Special issue: Sepsis Why have clinical trials in sepsis failed?
John C. Marshall
TRENDS IN MOLECULAR MEDICINE (2014)
Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF
Min Jiang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
E Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
